• iRhom2 Regulates Olfactory Receptor Activity and Adaptation

  2026-05-22

  Azzopardi et al. uncover a specialized role for iRhom2 in olfactory sensory neurons, showing that it modulates odorant receptor expression and activity-dependent adaptation via the ADAM17 pathway. These findings reveal a feedback mechanism that shapes olfactory gene repertoires in response to environmental odor stimulation, offering new insight into the molecular basis of olfactory plasticity.

• Refining In Vitro Cancer Drug Assessment: Insights from Schw

  2026-05-22

  Schwartz et al.'s dissertation rigorously distinguishes between relative and fractional viability as metrics for in vitro drug response in oncology, revealing that proliferation arrest and cell death are often conflated yet mechanistically distinct. These insights refine the interpretation of anticancer compound efficacy and provide a robust foundation for optimizing in vitro evaluation protocols.

• Adiponectin Mitigates Post-Surgery Cognitive Decline via TLR

  2026-05-21

  This study demonstrates that adiponectin administration prior to splenectomy in aged rats attenuates postoperative cognitive deficits by suppressing neuroinflammation and oxidative stress through inhibition of the TLR4/MyD88/NF-κB pathway. The findings offer mechanistic insight into perioperative neurocognitive disorder (PND) and suggest avenues for targeted intervention.

• Afatinib (BIBW 2992) for Advanced Cancer Assembloid Studies

  2026-05-21

  Afatinib (BIBW 2992) empowers high-fidelity modeling of EGFR family signaling in patient-derived cancer assembloids, bridging preclinical research with personalized therapy development. Its irreversible inhibition profile enables robust dissection of resistance mechanisms, especially when integrated into complex tumor–stroma co-culture systems.

• (S)-(+)-Dimethindene maleate for M2 Muscarinic Antagonist As

  2026-05-20

  (S)-(+)-Dimethindene maleate addresses the need for a highly selective M2 muscarinic receptor antagonist in studies of autonomic regulation, cardiovascular physiology, and respiratory system function. It is best suited for in vitro research where precise receptor discrimination is required, but should not be used in diagnostic or clinical settings due to its research-only designation.

• Dabigatran Etexilate: A Paradigm Shift in Oral Anticoagulati

  2026-05-20

  Dabigatran etexilate introduces a new approach to oral anticoagulation by directly inhibiting thrombin, bypassing cytochrome P450 metabolism and thus minimizing drug-drug interactions. This innovation addresses key limitations of traditional agents and has significant implications for both clinical and pharmacokinetic research.

• Biofilm Resistance and Hexetidine Efficacy on PVC Medical De

  2026-05-19

  This study elucidates how biofilm formation on poly(vinyl chloride) (PVC) endotracheal tubes rapidly increases bacterial resistance to both antibiotics and non-antibiotic antimicrobials. The research demonstrates that Hexetidine (NSC-17764) retains significant activity against established biofilms, highlighting its translational potential in device-associated infection management.

• N1-Methylpseudouridine: Modified Nucleoside for mRNA Transla

  2026-05-19

  N1-Methylpseudouridine is a modified nucleoside that enhances mRNA translation efficiency and reduces immunogenicity in mammalian systems. This compound, available from APExBIO, outperforms traditional nucleosides in protein expression and is validated across multiple cell lines and in vivo models.

• Graphene-FIR Triggers Apoptosis in Melanoma via Caspase-3 Pa

  2026-05-18

  This study demonstrates that graphene-mediated far-infrared radiation (FIR) induces apoptosis and hypoxic stress in malignant melanoma cells by activating caspase-dependent pathways. The use of caspase-3 inhibitors, such as Z-DEVD-FMK, provided strong mechanistic evidence for the centrality of caspase-3 in FIR-induced cell death, highlighting a promising direction for future therapeutic research.

• Unlocking Translational Power: 5-moUTP Modified Firefly Luci

  2026-05-18

  This thought-leadership article explores how 5-moUTP-modified Firefly Luciferase mRNA revolutionizes bioluminescent reporter assays and translational research. We detail the molecular innovations underpinning immune-evasive, stable, and efficient gene expression, contextualize APExBIO's EZ Cap™ Firefly Luciferase mRNA in the evolving landscape of RNA delivery, and provide strategic guidance for maximizing translational assay reliability. Grounded in mechanistic insights and recent advances in nanoparticle delivery, this article positions next-generation mRNA reporters as essential benchmarks for the future of functional genomics and therapeutic development.

• Cy5 TSA Fluorescence System Kit: Precision Amplification in

  2026-05-17

  Discover how the Cy5 TSA Fluorescence System Kit enables precise signal amplification for immunohistochemistry and in situ hybridization, facilitating advanced research into liver cell fate and maturation. This article uniquely connects the kit’s technical advantages to recent breakthroughs in spatial transcriptomics and Hippo signaling.

• Ibrexafungerp and Caspofungin: Efficacy Against Resistant C.

  2026-05-16

  Wiederhold et al. evaluated ibrexafungerp's in vitro and in vivo activity against fluconazole-resistant Candida auris, demonstrating significant efficacy even with delayed therapy initiation. These findings highlight the importance of targeting β-(1,3)-D-glucan biosynthesis for antifungal strategies and inform the ongoing development and optimization of antifungal protocols.

• MiR-3180 Suppresses HCC by Targeting Lipid Synthesis and Upt

  2026-05-15

  Hong et al. identify miR-3180 as a key suppressor of hepatocellular carcinoma (HCC) growth and metastasis through direct inhibition of SCD1 and CD36, critical regulators of lipid synthesis and uptake. Their multi-modal approach demonstrates that miR-3180 downregulation in HCC correlates with poor prognosis, suggesting its promise as both a therapeutic target and prognostic biomarker.

• Applied Workflows for 2-Deoxy-D-glucose in Cancer Metabolism

  2026-05-15

  Harness 2-Deoxy-D-glucose for precise glycolysis inhibition in advanced cancer models and metabolic pathway research. Discover protocol refinements, troubleshooting strategies, and data-driven guidance to unlock its full experimental potential.

• Aloin Isoforms Inhibit SARS-CoV-2 PLpro: Selectivity and Mec

  2026-05-14

  The referenced study identifies aloin A and B as selective inhibitors of the SARS-CoV-2 papain-like protease (PLpro), providing mechanistic insights into their dual inhibition of proteolytic and deubiquitinating activities. These findings clarify the molecular action of mouth rinse ingredients and have implications for both antiviral screening and the design of oral antimicrobial protocols.

16773 records 1/1119 page Next 12345 下5页 Last page